ARCHIVES

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

Group Backing Epstein Received Grants From Reynolds Foundation

May 15, 1992

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994